This online workshop offers a comprehensive and current overview of the bioanalytical strategies used in the development of therapeutic oligonucleotides. With the rapid evolution of oligonucleotide-based therapies, including new delivery technologies and molecular modalities, the demand for robust and innovative bioanalytical methods has never been greater. This session gathers leading scientists and industry experts to present on emerging techniques and best practices in pharmacokinetic (PK), anti-drug antibody (ADA), and biomarker analysis for oligonucleotide therapeutics.
Topics:
- Regulatory considerations for oligonucleotides
- Introduction to Oligonucleotides
- Metabolism of Oligos
- Approaches to PK Analysis of Oligonucleotides (LCMS, HRMS approach; HELISA; bDNA, qPCR or dPCR)
- Approaches to ADA Analysis of Oligonucleotides
- Further Advances in Oligonucleotide Modalities and impact on bioanalysis
- Advances in delivery (LNP, etc)
- Newest modalities (AOC, etc)
- Biomarkers for oligos
Click here to access the full event flyer.
Contact Us to Learn More and Start a Conversation
Are you attending PBSS? Don’t miss the chance to discuss your project’s needs with KCAS Bio. Contact us to schedule a meeting and explore how our services can support your bioanalytical and drug development objectives.